INV-347

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for INV-347, covering 2026-03-06 to 2026-03-06. Get the full timeline:

Most recent: Clinical Trial Update: Safety Follow-up Study of Participants Dosed With INV-347 in Study INV-CL-108 [Phase 1]